PPARA and obesity due to melanocortin 4 receptor deficiency: It has been suggested that PPAR ligands reduce obesity-associated comorbidities by acting on fat storage capacity of white adipose tissue and fat burning in brown adipose tissue and/or peripheral tissues (Gross et al., 2017).